logo

For the Inventor, By the Inventor

Singapore, Singapore

Hwei-Sing Jimmy Kwang

USPTO Granted Patents = 14

 

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 79(Granted Patents)


Company Filing History:

goldMedal14 out of 73 
 
Temasek Life Sciences Laboratory Limited
 patents
silverMedal1 out of 1 
 
National Institute of Health Research and Development (nihrd)-ministry of Health of the Republic of Indonesia
 patent
where one patent can have more than one assignee

Years Active: 2013-2019

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 10202617 - Expression cassette for efficient surface display of antigenic proteins (2019-02-12),
2. 9694067 - Monovalent H5 vaccine (2017-07-04),
3. 9637537 - Monoclonal antibodies targeting neutralizing epitopes on H7 influenza viruses (2017-05-02),
4. 9555093 - Universal vaccine against H5N1 lineages (2017-01-31),
5. 9315551 - Porcine circovirus type 2 vaccines (2016-04-19),
6. 9115188 - Monoclonal antibodies specific to hemagglutinin from influenza virus H5-subtype and uses thereof (2015-08-25),
7. 8992929 - Monoclonal antibody specific to major neutralizing epitope of influenza H5 hemagglutinin (2015-03-31),
8. 8574830 - Binding protein and epitope-blocking ELISA for the universal detection of H5-subtype influenza viruses (2013-11-05),
9. 8574581 - Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof (2013-11-05),
10. 8540996 - Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof (2013-09-24),
11. 8540995 - Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza A viruses and uses thereof (2013-09-24),
12. 8518696 - Production of homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection (2013-08-27),
13. 8444986 - Monoclonal antibodies specific to hemagglutinin from influenza virus H5-subtype and uses thereof (2013-05-21),
14. 8383121 - Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof (2013-02-26),

Title: Hwei-Sing Jimmy Kwang: A Pioneer in Vaccine Innovation

Introduction

Hwei-Sing Jimmy Kwang is an accomplished inventor based in Singapore, known for his significant contributions to the field of immunology and vaccine development. With an impressive portfolio comprising 14 patents, Kwang has dedicated his career to pioneering innovations aimed at enhancing disease prevention through vaccination.

Latest Patents

Among his latest inventions, Kwang has developed an expression cassette designed for efficient surface display of antigenic proteins. This invention utilizes an ie 1 promoter from the white spot syndrome virus, alongside various nucleic acid sequences that contribute to its functional prowess. Another notable patent is the Monovalent H5 vaccine, which focuses on creating a monovalent H5N1 vaccine strain. This innovative approach employs hemagglutinin (HA) engineering to provide cross-clade protection against the virus.

Career Highlights

Throughout his career, Kwang has been associated with reputable institutions such as Temasek Life Sciences Laboratory Limited and Temasek Life Sciences Laboratories Limited. His work at these organizations has been pivotal in furthering research and development in the field of vaccine technology.

Collaborations

Kwang has collaborated with esteemed researchers, including Fang He and Prabakaran Mookkan. These collaborations have not only enriched his contributions but also facilitated advancements in their shared research endeavors.

Conclusion

Hwei-Sing Jimmy Kwang stands out as a notable inventor whose work continues to shape the landscape of vaccine development. His innovative spirit and dedicated research have the potential to impact public health profoundly, making his contributions invaluable to the scientific community and society at large.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…